Eureka Genomics offers a range of products and services for NGS-based genetic testing, but we are always looking for new ideas and partnership opportunities. Our Next-Gen Genotyping (NGG) provide a unique opportunity to design low-cost, focused content panels in applications such as animal health, plant science and clinical research. The NGG offers an improved and economical alternative to traditional technologies for genotyping hundreds to thousands of samples using Next Generation Sequencing (NGS). The assay can be broadly applied to the detection of single nucleotide polymorphisms (SNPs), copy number variation (CNV), gene expression and methylation and is compatible with DNA or RNA from virtually any organism, even when genome information may be incomplete.
With diagnostics in development for human conditions such as colorectal cancer and pre-term birth, Eureka Genomics is taking NGS expertise and applying it to disease epidemiology and detection. Whether characterizing changes in microbial community composition associated with disease state or screening for validated biomarkers, Eureka Genomics is a trusted partner for molecular diagnostic development.
Are you setting up a new Next Generation Sequencing service lab? Considering extending your existing lab to include testing services to provide a revenue stream? Interested in working with Eureka Genomics to establish genetic testing centers throughout the United States and beyond? Eureka Genomics is a trusted partner in the design, implementation and commercialization of genetic testing facilities. From choosing an appropriate location to identifying the equipment and licensing the assays most suitable for particular services to helping you reach out to your Clients, Eureka Genomics can help
Eureka Genomics offers a variety of partnership opportunities for the creation of genetic testing facilities and related services.